Pyrrolopyrimidines and Pyrrolopyridines

Details for Australian Patent Application No. 2009203694 (hide)

Owner Novartis AG

Inventors Leblanc, Catherine; Stiefl, Nikolaus Johannes; Pulz, Robert Alexander

Agent Davies Collison Cave

Pub. Number AU-B-2009203694

PCT Pub. Number WO2009/087225

Priority 08150182.7 11.01.08 EP

Filing date 9 January 2009

Wipo publication date 16 July 2009

Acceptance publication date 26 April 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/087225 Priority application(s): WO2009/087225

26 April 2012 Application Accepted

  Published as AU-B-2009203694

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009203699-Display vectors and methods and uses thereof

2009203693-Pyrimidines as kinase inhibitors